Sensitivities Sample Clauses

Sensitivities. Most of the parameters estimated during model calibration were related to hydraulic conductivity (horizontal hydraulic conductivity, horizontal-flow barriers, drain conductances, vertical anisotropy, and depth decay) (fig. 25 and appendix 1). In addition, a number of pilot points were added to better quantify storage properties for the transient simulation (xxxxx- xxx 1). Of the more than 500 parameters, all were estimated in the combined steady-state and transient simulation. At times during the calibration process, some of the defined parameters were not estimated because they were relatively insensitive at that point of the calibration. Sensitivity was measured by using composite-scaled sensitivities (CSS) that allow compari- sons of parameters of different units by scaling them to obtain quantities with the same units. CSS present the amount of information that observations provide to estimate the individ- ual parameter (Hill and Xxxxxxxx, 2007). Like DVRFS v. 1.0, recharge and depth decay of horizontal hydraulic conductivity are some of the most sensitive parameters in DVRFS v. 2.0, although some volcanic-rock and basin-fill hydraulic-con- ductivity, vertical anisotropy, and storage parameters are also among the most sensitive parameters. Parameter Correlation Parameter correlation coefficients (PCC) were used to eval- uate whether model parameters could be estimated uniquely by regression (Xxxx and Xxxxxxxx, 2007, p. 53). A PCC with an absolute value close to 1.00 indicates that the two param- eters involved likely cannot be estimated uniquely. Generally, absolute values greater than 0.95 are cause for concern, but values as small as 0.85 can affect the uncertainty of parameter estimates.‌‌‌‌‌ Of the more than 500 parameters only 4 had PCCs greater than 0.95, all of them pilot points. All of these sets (parameter pairs) are negatively correlated, meaning that as one parameter is increased the other will decrease, and all of these param- eters have relatively low sensitivities, less than 1 x 10-3. The correlation of these four sets of parameters may not be able to be uniquely estimated. Two of the best most highly correlated parameter sets were for hydraulic conductivity in the basin- fill deposits in northwest Pahrump Valley, and two of the sets were for pilot point specific-yield parameters occurring in the basin-fill deposits near Indian Springs, Nevada: kvf_18 and kvf_22: -0.98 kvf_24 and kvsu_u_24: -0.99 pp_ss88 and pp_ss92: -0.99 pp_ss91 and pp_...
Sample 1
AutoNDA by SimpleDocs

Related to Sensitivities

  • Regulatory Activities Beginning on the Effective Date and to the extent UGNX remains the Lead Development Party with respect to a particular territory, subject to and in accordance with the terms and conditions of this Agreement and the requirements of Applicable Laws, UGNX, shall: (a) use Commercially Reasonable Efforts to file (or have filed) all Regulatory Filings with respect to the Licensed Products in the Field in order to obtain Marketing Approvals in each country in the Territory and the European Territory (or to obtain the European Centralized Approval in the European Core Territory) and in order to obtain Pricing and/or Reimbursement Approvals in the Profit Share Territory; (b) respond in a timely fashion to requests for data and information from Regulatory Authorities with respect to the Licensed Products in the Field in the Territory and the European Territory; and (c) meet with officials of the Regulatory Authorities at such times as may be requested by such Regulatory Authorities with respect to the Core Development Activities (“Regulatory Activities”), provided that KHK will have primary responsibility for obtaining, and UGNX shall provide all assistance reasonably requested by KHK, in relation to Pricing and/or Reimbursement Approvals for the Licensed Products in the Field in the European Territory. For the avoidance of doubt, UGNX will be responsible for obtaining, and KHK will provide all assistance reasonably requested by UGNX, in relation to Pricing and/or Reimbursement Approvals, if any, for the Licensed Products in the Field in the Profit Share Territory as part of the UGNX Core Development Activities, it being understood that the costs incurred by UGNX in connection with such activities will be shared equally (50/50). All such Regulatory Activities will be conducted in a manner consistent with the Core Development Plan and coordinated by the JSC in accordance with Article 3. Without limiting the applicability of the foregoing and the remainder of this Article 5, UGNX shall interface with the applicable Regulatory Authority(ies) and, through the JDC, shall keep KHK reasonably informed of all material events and developments occurring in the course of the Regulatory Activities, including scheduled UGNX regulatory strategy discussions and meetings with Regulatory Authorities in the Territory and the European Territory relating to the Licensed Products in the Field.

  • Complexity Intermediate professional level role. Provides data warehouse architectural design, development and support in multi-platform environments. Works on multiple projects as a team member and may lead projects of moderate complexity. May coach more junior technical staff.

  • Expertise Such Member alone, or together with its representatives, possesses such expertise, knowledge and sophistication in financial and business matters generally, and in the type of transactions in which the Company proposes to engage in particular, that such Member is capable of evaluating the merits and economic risks of acquiring and holding the Units, and that such Member is able to bear all such economic risks now and in the future;

  • Screening 3.13.1 Refuse containers located outside the building shall be fully screened from adjacent properties and from streets by means of opaque fencing or masonry walls with suitable landscaping.

  • Constraints The Joint Committee on Benefits will not make any changes to the plan provisions that would increase the costs of health and welfare benefits or disability benefits for individual employers or reduce plan provisions without the agreement of the Parties to this Agreement. The Joint Committee shall be authorized to determine appropriate use of the Article 9.1.3 savings from the 1998-2001 agreement (in the amount of $71,849) and to allocate the funds to that use.

  • Capabilities A. The Parties agree that the DRE must possess the legal, technical, and financial capacity to:

  • Activities Except with the prior written consent of the Board, Executive will not during his employment with the Company undertake or engage in any other employment, occupation or business enterprise, other than ones in which Executive is a passive investor. Executive may engage in civic and not-for-profit activities so long as such activities do not materially interfere with the performance of his duties hereunder.

  • Studies The clinical, pre-clinical and other studies and tests conducted by or on behalf of or sponsored by the Company or its subsidiaries that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus were and, if still pending, are being conducted in accordance in all material respects with all statutes, laws, rules and regulations, as applicable (including, without limitation, those administered by the FDA or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA). The descriptions of the results of such studies and tests that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus are accurate and complete in all material respects and fairly present the published data derived from such studies and tests, and each of the Company and its subsidiaries has no knowledge of other studies or tests the results of which are materially inconsistent with or otherwise call into question the results described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, neither the Company nor its subsidiaries has received any notices or other correspondence from the FDA or any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA with respect to any ongoing clinical or pre-clinical studies or tests requiring the termination or suspension of such studies or tests. For the avoidance of doubt, the Company makes no representation or warranty that the results of any studies, tests or preclinical or clinical trials conducted by or on behalf of the Company will be sufficient to obtain governmental approval from the FDA or any foreign, state or local governmental body exercising comparable authority.

  • Feasibility Each of the Project Budget, the Project Schedule and the Disbursement Schedule is realistic and feasible.

  • Cultural ceremonial leave may be taken as whole or part days off. Each day or part thereof, shall be deducted from:

Time is Money Join Law Insider Premium to draft better contracts faster.